Freenome alternatives and competitors
The closest alternatives to Freenome are GRAIL, bioAffinity Technologies, Guardant Health and Veracyte.
Cancer screening company (NASDAQ: FRNM) whose blood tests run on a multiomics platform that reads cell free DNA methylation at single base resolution, alongside protein and autoantibody signals, with machine learning classifiers producing the result.
8 alternatives to Freenome
What each product does, with its price as the vendor publishes it.
-
G
Multi cancer early detection company (NASDAQ: GRAL). The Galleri test uses targeted methylation sequencing of cell free DNA from a blood draw, with machine learning classifiers that detect a cancer signal and predict its origin, across more than 50 cancer types.
Price: $949 per test (list price)
-
B
bioAffinity Technologies (NASDAQ: BIAF) develops noninvasive tests for lung disease, led by CyPath Lung, a laboratory developed test that pulmonologists and other physicians order for high risk patients with indeterminate pulmonary nodules.
Price: No published price
-
G
Guardant Health is a publicly traded precision oncology company (Nasdaq: GH), founded in 2012 and based in Palo Alto, California, that runs blood and tissue cancer tests in its own laboratories.
-
V
Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.
Price: No published price
-
C
Caris Life Sciences (NASDAQ: CAI) is a precision oncology company in Irving, Texas. It profiles tumors in its own laboratories by whole exome and whole transcriptome sequencing and layers AI signatures on the results.
Price: No published price
-
W
Waiv sells AI tests that read routine H&E slides, for pathology laboratories and oncology teams in Europe, and biomarker services for drug developers.
Price: No published price
-
D
Histotype Px Colorectal predicts recurrence and survival in stage II and III colorectal cancer from standard H and E stained slides, placing patients in low, intermediate or high risk groups to inform whether adjuvant chemotherapy should follow surgery.
Price: No published price
-
S
Respiratory diagnostics company developing Sylvee, a chest worn wearable that projects low frequency sound into the lungs and analyzes the returning resonance with machine learning to measure lung volumes, trapped air, respiratory rate and breathing sounds, positioned for early COPD…
Price: No published price
Freenome alternatives, answered
What are the best alternatives to Freenome?
The closest alternatives to Freenome are GRAIL, bioAffinity Technologies, Guardant Health, Veracyte and Caris Life Sciences. bioAffinity Technologies (NASDAQ: BIAF) develops noninvasive tests for lung disease, led by CyPath Lung, a laboratory developed test that pulmonologists and other physicians order for high risk patients with indeterminate pulmonary nodules. Guardant Health is a publicly traded precision oncology company (Nasdaq: GH), founded in 2012 and based in Palo Alto, California, that runs blood and tissue cancer tests in its own laboratories. Veracyte sells genomic tests that pair a laboratory expression assay with a learned classifier, used by urologists, oncologists and endocrinologists to decide how intensively to treat a cancer or whether a thyroid nodule needs surgery.
Who are Freenome's competitors?
Freenome's competitors in the Diagnostics & Genomics category include GRAIL, bioAffinity Technologies, Guardant Health, Veracyte and Caris Life Sciences.